Sigma-Aldrich
phone number
  • Exposing new perspectives on the role of Epigenetics in biology.
  • Detection and analysis of environmental contamination from oil spills.
  • Partnering with you to meet your Diagnostic manufacturing needs.
  • Chemistry Green Science
  • Materials Science Online Product Catalog
Decrease Font Size Increase Font Size Email this page to a friend Printer Friendly Page



 
 
 
 
 
 
Your Favorite Gene - Powered by Ingenuity
Your Favorite Gene Search
 
 
Sign Up Here For Free
News & Information
 

We know that along with quality, consistent fast delivery is key when choosing your oligonucleotide supplier. With our local UK manufacturing facility offering 100% QC on every oligonucleotide that we synthesise, we are ideally placed to deliver the quality that you require when your research needs it – even when flights are grounded!

For more details of our synthesis service please call us on 0800 269016 or visit
our Oligo web portal

 

New Distribution Agreement With Boehringer Ingelheim Offers Sigma-Aldrich Customers Expanded Biodegradable Polylactide Polymers for Biomaterials Research.
ST. LOUIS, April 8, 2010 /PRNewswire via COMTEX News Network/ -- Sigma-Aldrich(R) (Nasdaq: SIAL) announced today it has entered into a distribution agreement with Boehringer Ingelheim Pharma GmbH & Co. KG, Germany, to offer its portfolio of RESOMER biodegradable polylactide (PLA) and poly(lactide-co-glycolide) (PLGA) polymers to the research community. Read More...

We now have over 33,000 antibodies available. Find out more about our NO RISK TRIAL programme here.
Few if any antibodies can be guaranteed to work in all applications. That is why select* Sigma Antibodies come with a no risk trial guarantee. If a Sigma Antibody does not give you the result you expect, you will get a full refund.
Simply quote promotion code T71 with your order to qualify.
Read More...

  • Offer excludes Prestige and FLAG Antibodies.
  • Valid until 31st december 2010
  • Cannot be used in conjunction with any other offer
BACK   |   NEXT